Explore evidence

68.1 %La prévalence de la neuropathie chez les personnes vivant avec le VIH au Kenya était de 68,1 % en 2020.

KenyaVIH/sidaobserved 2020HAL · Unilimdocument of 747 observations

210,000 casesIn 2023, over 210,000 new HIV acquisitions occurred in Kenya, Mozambique, Nigeria, Uganda and Zambia.

Kenya · Mozambique · Nigeria · Ouganda · ZambieVIH/sidaobserved 2023published 2025Journal of the International AIDS SocietyPubMeddocument of 2 observations

41 %Among 70 transfeminine participants, 28 (41%) were HIV-positive.

KenyaVIH/sidaobserved 2017published 2021The lancet. HIVPubMeddocument of 14 observations

40.8 %Among 1,500 intervention participants, 250 (40.8%) men were late retesters.

KenyaVIH/sidapublished 2022BMC public healthPubMeddocument of 9 observations

0.66 adjusted_hazard_ratioCompared to the pre-COVID-19 period, the COVID-19 period had lower six-months non-retention with an adjusted hazard ratio of 0.66 (95% CI: 0.58–0.74).

KenyaVIH/sidaobserved April 2020–March 2021 vs. pre-COVID-19published 2023PloS onePubMeddocument of 7 observations

5.14 relative_riskMothers unaware of their partners’ HIV status had a relative risk of 5.14 for infant HIV positivity at 12 months.

KenyaVIH/sidaobserved 12 monthspublished 2023European Journal of Public HealthOpenAlexdocument of 7 observationsDOI 10.1093/eurpub/ckad160.824

18 %In a competing risk model, viral suppression increased by 18% for each additional year of age among pregnant and postpartum women living with HIV attending a large referral facility in Kenya from 2015 to 2019.

KenyaVIH/sidaobserved 2015 to 2019published 2022AIDS and behaviorPubMeddocument of 4 observations

1.51 odds_ratioPrincipal component 1 (PC1), comprising VEGF, MIP-1β, VEGF-C and IL-4, was significantly associated with HIV-1 acquisition with an adjusted odds ratio of 1.51 (95% CI: 1.14–2.00) and p=0.004.

KenyaVIH/sidapublished 2023Frontiers in immunologyPubMeddocument of 3 observations

14 mutationsOut of 17 new mutations, 14 resulted in virologic failure.

KenyaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 3 observations

23,262 patientsA total of 23262 (84.2%) of the 27641 patients eligible for early refill received an extra 3-month supply of antiretrovirals in Kisumu County, Kenya during the coronavirus disease 2019 pandemic.

KenyaVIH/sidapublished 2020AIDS (London, England)PubMeddocument of 2 observations

81 %Among 97 children with HIV on isoniazid preventive therapy, 81% were virally suppressed (<1000 copies/ml).

KenyaVIH/sidaobserved 2019 through 2020published 2024AIDS (London, England)PubMeddocument of 5 observations

3 self-testsParticipants offered a median of three self-tests to sexual partners.

KenyaVIH/sidapublished 2020Journal of the International AIDS SocietyPubMeddocument of 15 observations

8.3 %Among HIV-infected patients in Central Kenya, those on TB treatment during their last known visit decreased from 8.3% in 2004 to 3.9% in 2014.

Kenyatuberculose · VIH/sidaobserved 2004 to 2014published 2021BMC infectious diseasesPubMeddocument of 10 observations

74 %Of the 230 participants encouraged to stop PrEP according to strategy recommendations, 170 (74%) did so.

KenyaVIH/sidapublished 2020BMC public healthPubMed

86 %86% of the adolescents and young adults living with HIV were satisfied with the disclosure process.

KenyaVIH/sidaobserved 2019published 2023Frontiers in public healthPubMeddocument of 18 observations

93 %At baseline, 56 out of 60 participants living with HIV (93%) had initiated antiretroviral therapy.

KenyaVIH/sidapublished 2023BMC health services researchPubMeddocument of 12 observations

-45 USDBetter management was associated with lower unit costs for HIV testing services (HTS) of $-45.

KenyaHIV testing services (HTS) · VIH/sidapublished 2025PloS onePubMeddocument of 8 observations

1,694 individualsAmong children and adolescents living with HIV in central Kenya, 1,694 (35.1%) were enrolled at WHO stage III disease.

KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations

4.58 per_100_PYARA total of 8 cases of HIV infection were observed in 174.5 Person Years at Risk (PYAR), all among MSM, resulting in an HIV incidence of 4.58 cases per 100 PYAR among MSM enrolled in the study.

KenyaVIH/sidapublished 2022BMC public healthPubMeddocument of 11 observations

73 %The proportion of adolescents and young people living with HIV on antiretroviral therapy with unsuppressed viral load who completed three enhanced adherence counselling sessions rose to 73% during the implementation period.

KenyaVIH/sidaobserved from March 2019 to July 2020published 2022BMJ open qualityPubMeddocument of 8 observations

Malaria co-infection was not associated with worsened leucopenia in people living with HIV.

Kenyaleucopenia · paludisme · VIH/sidapublished 2023International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 8 observations

No vaccine-related serious adverse events were reported in Phase I and IIA HIV vaccine trials enrolling healthy, HIV-seronegative African volunteers.

KenyaVIH/sidaobserved 2001-2007published 2014Human vaccines & immunotherapeuticseurope_pmcdocument of 10 observationsDOI 10.4161/hv.27559

4 hazard_ratioHaving a nonpaying, regular partner was associated with an increased pregnancy risk with an adjusted hazard ratio of 4.0 among female sex workers living with HIV in Mombasa, Kenya.

KenyaVIH/sidaobserved October 2012-April 2017published 2020Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 10 observations

2.2 per_100_person_yearsHIV incidence was 2.2 per 100 person-years among African adolescent girls and young women in the POWER study.

KenyaVIH/sidapublished 2022Journal of the International AIDS SocietyPubMeddocument of 12 observations

35 %Tuberculosis/HIV coinfection rate was 35% among the cohort of 291 patients in Vihiga County.

Kenyatuberculose · VIH/sidapublished 2023African health sciencesPubMeddocument of 6 observations